
Philippines: FDA Advisory No. 2025-0095-A || Lifting of the Advisory on the Interim Extension of Renewal Application Period of LTO Prior to Expiration of Validity Under FDA Advisory No. 2025-0095
The Food and Drug Administration (FDA) informs its stakeholders that effective immediately, all applications for renewal of License to Operate (LTO) shall revert to the prescribed renewal period of ninety (90) calendar days prior to its expiration, following Administrative Order 2024-0015, titled “Prescribing the Rules, Requirements and Procedures in the Application




